Nigeria

The framework calls on countries to maintain high-quality disease surveillance, preserve laboratory and emergency response capacity, strengthen routine immunization and secure sustainable domestic financing.

The issuance forms part of Emzor’s broader US$29.6 million bond programme, which is designed to provide capital for the company’s growth and operational needs.

During the first phase of the study, conducted in Osun State from 2023 to 2025, children who received PMC experienced a 22% reduction in confirmed malaria cases. Overall health facility visits for illness also fell by 19%.

The partnership will support Nigeria’s post-marketing vaccine surveillance system by evaluating innovative screening devices and expanding routine laboratory testing for vaccine lots.

The procedure, carried out in Damaturu, represents the first time such an advanced maxillofacial surgery has been conducted in a state-owned hospital in the region.

The launch brings together national and international health stakeholders who are supporting Nigeria’s broader HIV response strategy.

The Sokoto deployment builds on findings from an extensive randomized controlled implementation study conducted in Nigeria in collaboration with PATH, Jhpiego, the National Primary Health Care Development Agency, and Sydani Group.

The project received financial backing from First City Monument Bank (FCMB) and the Bank of Industry (BoI), reflecting a coordinated push to support local industry growth.

Lenacapavir complements existing prevention methods such as oral pre-exposure prophylaxis and long-acting injectable cabotegravir.

Trained health workers will conduct house-to-house visits and set up vaccination points at designated community locations to maximise coverage.